Clinical trial

Zusanli (ST36) Electroacupuncture Treatment for Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer

NCT07076836

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DEVICE · Unmapped registry intervention Acupuncture Find medicine records · Find other trials using this name

DEVICE · Unmapped registry intervention sham acupuncture Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Zusanli (ST36) Electroacupuncture Treatment for Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer

Design: INTERVENTIONAL · Status: RECRUITING · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-08-31

PhaseNA

Conditions

Lung Cancer (NSCLC)unresolved

Immune Checkpoint Blockadeunresolved

Electroacupunctureunresolved

Interventions

AcupunctureDEVICE

sham acupunctureDEVICE

Sponsors & collaborators

West China Hospitallead sponsor

Mapped research locations

ChengduSichuan, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07076836 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.